Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2002;106:1592-1594
doi: 10.1161/01.CIR.0000033309.35425.A6
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Popma, J. J.
Right arrow Articles by Baim, D. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Popma, J. J.
Right arrow Articles by Baim, D. S.
Related Collections
Right arrow Catheter-based coronary and valvular interventions: other
Right arrow Catheter-based coronary interventions: stents
Right arrowRelated Article

(Circulation. 2002;106:1592.)
© 2002 American Heart Association, Inc.


Editorial

A Decade of Improvement in the Clinical Outcomes of Percutaneous Coronary Intervention for Multivessel Coronary Artery Disease

Jeffrey J. Popma, MD; Richard E. Kuntz, MD, MSc; Donald S. Baim, MD

From the Department of Internal Medicine, Cardiovascular Division, Brigham and Women’s Hospital, Boston, Mass.

Correspondence to Donald S. Baim, MD, Center for Integrating Medicine and Innovative Technology (CIMIT), Brigham and Women’s Hospital, 75 Francis St, Boston, MA 02115. E-mail dbaim@partners.org


Key Words: Editorials • coronary disease • revascularization • vessels • stents


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Twenty-five years after its tentative beginnings, percutaneous coronary intervention (PCI) has become the dominant form of coronary revascularization. This year, the 800 000 PCI procedures are more than double the number of coronary artery bypass graft (CABG) surgeries. Although there had already been substantial growth throughout the 1980s and early 1990s as a result of improving equipment and techniques for conventional balloon angioplasty, the accelerated growth since 1994 has clearly been fueled by the rapid adoption of coronary stenting. Today, >80% of PCI procedures involve stent placement, supported by a series of randomized trials that have demonstrated better acute angiographic results, reduced emergency surgery, and reduced recurrence rates (restenosis) when stents are placed properly with an effective antiplatelet regimen. In practice, however, the excellent results in the circumscribed lesion types studied in the key randomized trials have been generalized to other lesion morphologies (eg, small vessel, diffuse disease, bifurcation lesions) for which the evidence supporting stent use is less clear. Over the past several years, there has been a concurrent increase in the use of platelet glycoprotein IIb/IIIa inhibitors as an adjunctive therapy during PCI. A plethora of randomized clinical trials demonstrate that these agents are very effective in reducing periprocedural myocardial infarction, defined as elevation of cardiac enzymes.1–3

See p 1627

Taken together, these 2 advances have made PCI faster, safer, and more durable than in the pre-1990 era in which Plain Old Balloon Angioplasty (POBA) was the only form of PCI available. Emergency bypass surgery to treat an . . . [Full Text of this Article]


Related Article:

Contemporary Percutaneous Coronary Intervention Versus Balloon Angioplasty for Multivessel Coronary Artery Disease: A Comparison of the National Heart, Lung and Blood Institute Dynamic Registry and the Bypass Angioplasty Revascularization Investigation (BARI) Study
V.S. Srinivas, Maria Mori Brooks, Katherine M. Detre, Spencer B. King, III, Alice K. Jacobs, Janet Johnston, and David O. Williams
Circulation 2002 106: 1627-1633. [Abstract] [Full Text]



This article has been cited by other articles:


Home page
HeartHome page
H C Lowe, B James, and L M Khachigian
A novel model of in-stent restenosis: rat aortic stenting
Heart, March 1, 2005; 91(3): 393 - 395.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
D. A. Morrow
Preprocedural C-Reactive Protein for Risk Prediction Before Percutaneous Coronary Intervention (PCI): A US Perspective
Clin. Chem., September 1, 2004; 50(9): 1489 - 1491.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. J. Epstein, S. S. Rathore, K. G. M. Volpp, and H. M. Krumholz
Hospital percutaneous coronary intervention volume and patient mortality, 1998 to 2000: Does the evidence support current procedure volume minimums?
J. Am. Coll. Cardiol., May 19, 2004; 43(10): 1755 - 1762.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. L. Orford, A. Lerman, and D. R. Holmes
Routine intravascular ultrasound guidance of percutaneous coronary intervention: A critical reappraisal
J. Am. Coll. Cardiol., April 21, 2004; 43(8): 1335 - 1342.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
V.S. Srinivas, M. M. Brooks, K. M. Detre, J. Johnston, S. B. King III, A. K. Jacobs, and D. O. Williams
A Decade of Improvement in the Clinical Outcomes of Percutaneous Coronary Intervention for Multivessel Coronary Artery Disease
Circulation, April 8, 2003; 107 (13): e88 - e88.
[Full Text] [PDF]